-
Mashup Score: 0
Investigators compared linagliptin with standard of care treatment for clinical outcomes in people with type 2 diabetes who were hospitalized with COVID-19.
Source: Endocrinology AdvisorCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 7
Commentary by Dr. Douglas Mann
Source: www.jacc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Adding linagliptin to glimepiride treatment reduces some measures of glycemic variability and improves glycemic control in patients with HNF1A-MODY, indicate findings from the GLIMLINA trial.
Source: diabetes.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
#Linagliptin did not reduce time to clinical improvement in patients with #T2D who were #hospitalized with #COVID-19. https://t.co/yJBSTVcCem